The WHO chief urged all countries to share true statistics so as to contribute to a more effective fight against the spread of the disease. Last week, Tedros asked China for reliable data on Covid hospitalizations and deaths in the country.
This comes as a major outbreak has ripped through China's urban centers in the wake of an abrupt relaxation of disease control last month, CNN reported. The World Health Organization (WHO) officials have become increasingly vocal in their calls for reliable information.
Incidentally, the scale of the current outbreak of the Covid infections has made it difficult for the authorities to track the Covid infections, following the end of the mandatory mass testing as part of the easing of Covid restrictions.
This comes as WHO held a high-level meeting with counterparts in China last week to discuss the surge in cases and hospitalisations. Subsequently, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution and the COVID-19 clinical management expert network groups both met with Chinese
The United States on Wednesday said that the restrictions imposed on flyers from China are because of the "lack of adequate and transparent" data from Beijing over the omicron subvariants that has the potential to spread beyond its borders.
In the high-level meeting, WHO asked for more genetic sequencing data, data on disease impact including hospitalisations, intensive care unit (ICU) admissions and deaths -- and data on vaccinations delivered and vaccination status, especially in vulnerable people and those over 60 years o
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus on Friday said that the global body remains concerned over the evolving situation in China as the COVID-19 infections witness a new spike in the country after curbs were eased.
Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral
Three years after its emergence in China's Wuhan, exactly how SARS-CoV-2 first emerged as a respiratory pathogen capable of sustained human-to-human transmission remains the subject of active debate.
"The situation is quite unprecedented, for not only we are seeing more outbreaks, but these outbreaks are larger and more deadly than the ones we have seen in past years," said Barboza. "This increasing number of cholera outbreaks is occurring after several years of regular reduction in the